This tool guides HCV treaters through baseline factors involved in making treatment decisions and emphasizes how responses to therapy affect on-treatment management decisions. The tool is based on current published treatment guidelines, and is enhanced with expert data analysis by Emmet B. Keeffe, MD, MACP, who highlights for users the new and evolving data that may weigh in on treatment decisions for HCV-infected patients.